The project
Investigating Mechanisms of Recurrence After Immune Gene Therapy in G34-Mutant Pediatric High-Grade Glioma
PCF's published Our Impact description, checked September 15, 2026. Planned trial, enrollment and site language below is source wording, not a current trial-status update.
This study investigates why G34-mutant childhood brain tumors often recur after treatment, aiming to guide immune-based combination therapies that improve long-term survival.